Carl J. Danzig, MD | Image Credit: Rand Eye Institute A recent study reaffirmed the safety and efficacy of using faricimab to treat macular edema due to retinal vein occlusion (RVO) by reducing vascular endothelial growth factor (VEGF). The study was a secondary phase of the BALATON and COMINO trials, which met their primary endpoints … Read more
A recent cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES) data conducted in Tianjin revealed that the systemic inflammatory response index can be used to successfully identify age-related macular degeneration (AMD). “These findings suggest that [the index] could be used as a biomarker for AMD risk assessment, which can greatly benefit patient care,” … Read more
A recent prospective cohort study conducted in Hong Kong revealed a substantial linkage between simultaneous exposure to multiple air pollutants and age-related eye disease incidence. “Given that individuals are exposed to a complex mixture of air pollutants and that high collinearity exists among different pollutants, estimating the combined effect of multiple air pollutants on human … Read more